革兰阳性球菌感染抗菌治疗进展

[27].WilleyBM TrpeskiL Pong-PorterS etal. Theinvitmac- tivities of ABT 773 talithmmycin and other ncmlides against anadian streptococciLCJ. 40th ICAAC Abstract E2161 Toron- to Ontario Canada 2000.

[28]. SuImnE NarcaurF MauriacC etal. HMR3647 anewkemlidentimicrobial is metabolized and excreted mainly in faeces in manLJJ J Antlmicmb Chemother 1999. 44(Suppl. A)54.

[29]. Pradban R S Gustavson L E Londo D D et al, Single oraldose pharmacokineties and safety of ABT-773 in healthy subjects (C) 40th ICAAC Abstract A2135 Toronto Ontario Canada 2000.

[30].Leroy B Manickam R. Efficacy of ketolide talithromycin tHMR 3647) in the treatment of bacteremia associated withcommunity-aguired pneumonia (C) . 40th ICAAC AbstractL2223 Toronto Ontario Canada 2000.

[31]. Deabate C A Heyder A Leroy B et al. Oral talithromyein LHMR 3647. 800ng odJ for 5 days in well tolerated and as effective as cefuroxime axeti[k 500rug bid) for 10 days in adults with acute excerbatlons of chronic hronehitisLAECB)LCJ. 40tb ICAAC Abstract L2228 Toronto Ontario Canada 2000.

[32]. Leray B Manickam R. Efficacy of telithromycintHMR3647) a new ketolide antin,icrobial in community-acquired pnenmonia caused by atypical pathogens. 40th ICAAC Abstract L2225 Toromo Ontario Canada 2000.

[33].Kueers A Crowe S M Gray~n M L Hoy J F. The UR of AmibioticsLMJ. $th ed Oxford' Bulterworth Heincraeam ADivision of Reed Educational and Professional Publishing Ltd 1997 423-427.

[34].FalminghamD RobbinsMJ Mathiasl L etal. Ln vitro activity of fampenem an oral pancm(C). 40th ICAAC Abstract E361 Toronto Ontario Canada 2000.

[35].Schuehly U Voith B Voigt U et al. Safety tolerability and phannacokinetics following multiple oral doses of faropenam daloxate and impact on fecal and oral flora(C). 40th ICAACA494 Toronto Ontario Canada 2000.

[36].SiaghKV CoqueTm MurmyBE. Ln vitro activity of the trinem sanfelrinem( GV104326) against gram-pasifive organlsms(J). Antimicrob Agents Chemother 1996 40; 2142-2146.

[37].Fuchs P C Barry A L Brown S D. In vitro activities of SCH27899 alone and in combination with 17 other antimicrobialagcntskJJ. Antimicrob Agents Cbemother 1999- 43:2996-2997